BNL Food Investment v. Martek Biosciences Corp.
BNL Food Investment v. Martek Biosciences Corp.
BNL Food Investment v. Martek Biosciences Corp.
It contends this
interpretation excludes resellers, companies that make their own DHA and ARA but do not sell to others, and product given away for testing purposes from the relevant product market. Id. at 32.
Despite Marteks argument, under the interchangeability test there is no reason for the market to exclude resellers of DHA and ARA. There is no
evidence that DHA and ARA that has been resold differ from BNLfoods DHA and ARA--nor does Martek argue such. Despite arguably unclear pleading by
BNLfood, under the interchangeability rule, a reasonable jury could find that resellers are included in BNLfoods definition. at 404; Def. Ex. 2 at 134:6-20. See DuPont, 351 U.S.
formula who make their own DHA and ARA or distribute the phospholipids without change can be found to be included in the market. See Berlyn, 73
F. Appx at 852-53 (adjusting analysis of market to the relevant consumer when improperly pled and argued). Marteks argument about BNLfoods
description of the alleged market is too restrictive--its focus should be on the realities and operations of that market. See id. Martek has not